Robert Langreth
Aetna rallies after WSJ reports CVS in talks to acquire insurer
NEW YORK - Aetna Inc. gained in New York trading after the Wall Street Journal reported that CVS Health Corp. is in talks to...
Amazon looms over drugstores as analysts see market entry
NEW YORK - Amazon.com Inc. is almost certain to enter the business of selling prescription drugs by 2019, said two analysts at Leerink Partners,...
Walgreens scraps Rite Aid takeover, will buy stores instead
NEW YORK - Walgreens Boots Alliance Inc. is scrapping its deal to buy all of rival Rite Aid Corp. and instead will buy a...
Express Scripts plunges after losing biggest client Anthem
NEW YORK - Express Scripts Holding Co. shares fell after the company said it expects to lose its biggest customer, health insurer Anthem Inc.,...
Gilead executive says pharmacy benefit managers keep prices high
NEW YORK - Gilead Sciences Inc.’s hepatitis C cure set off a firestorm of criticism over high drug prices in 2014 that hasn’t let...
Walgreens and Rite Aid cut deal price, may sell more stores
NEW YORK - Walgreens Boots Alliance Inc. and Rite Aid Corp.’s giant drugstore merger got smaller Monday after the companies, facing roadblocks from antitrust...
Rigging charge exposes fish tale behind antibiotic prices
NEW YORK - At least twice a week, Tanja Vanderlinde says patients call in to say they can’t afford drugs.
High-deductible health plans mean they...
Drug spending slowed in 2015 after discounts, CVS Health says
NEW YORK - CVS Health Corp. said drug costs for its plans grew a modest 5 percent in 2015, far less than the 11.8...
CVS profit in line with estimates as pharmacy sales increase
WOONSOCKET - CVS Health Corp. earnings matched analysts’ earnings estimates in the fourth quarter, after the August acquisition of nursing-home pharmacy Omnicare helped drive...
CVS makes exclusive deal to cover Amgen’s cholesterol drug
CVS Health Corp.’s drug-benefits unit will cover Amgen Inc.’s new cholesterol-cutting injections while excluding a competing treatment from Sanofi and Regeneron Pharmaceuticals Inc., pushing...
- Featured Event -
